ArticleFrontiers in endocrinology2026

Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date.

Elise Van der Borght et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.